You are here: About us > Arkopharma in brief
Last publication: 27/08/2015
Founded in 1980 in Carros, near Nice in France, by Dr. Max Rombi, Arkopharma is a pharmaceutical laboratory specialised in the area of phytotherapy, natural medicine and dietary supplements. By offering a global approach to health and well-being, ARKOPHARMA Pharmaceutical Laboratories meets consumers' needs. It offers natural medicines intended for treatment and prevention, increases consumption oriented towards family self-medication, and also offers healthcare professionals new possibilities for prescriptions.
For 34 years, ARKOPHARMA Laboratories has been dedicated to new “healthy medicines” based on natural products. It has been a period marked by the search for a healthier life and for essential values; phytotherapy and dietary supplements are favoured by an ever expanding number of consumers around the world.
Max Rombi was a veterinarian who was passionate about phytotherapy. In 1980 he decided to focus on this passion. He created Arkopharma Laboratories to modernise the old-fashioned image of how plants were used in pharmacy. He was then at the origin of the greatest discoveries and innovations in phytotherapy. These include Arkogélules®, the first capsules based on natural active ingredients. In 2008, Dr Rombi entrusted management of the Group to one of his sons, Philippe, who became the president of the Board of Directors, at the age of 47.
On 3rd July 2014, the Arkopharma Group was purchased by MONTAGU Private Equity, one of Europe’s leading private equity firms. Founded in 1968, MONTAGU benefits from over 40 years’ experience and has completed transactions with several hundreds of companies from numerous sectors including the health sector and agribusiness, thanks to a team divided between the company’s five European offices: Paris, London, Manchester, Frankfurt and Warsaw.
The acquisition by MONTAGU will provide new stimulation for the Group’s development.
The Group’s new governance is as follows:
Benoit Adelus, President of SEBIA, who presides over the strategic committee
Sylvain Berger Duquene, Director of Montagu France and Germany
Pascal Ambrosi, Associate Director of Montagu France
Raphael Candelier, Investment Director of Montagu France
Jacques Chevallet, President of the Board of Directors
Jean-Jacques Robert, Chief Executive Officer